Posts by: Joana Carvalho, PhD

Joana Carvalho, PhD

Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.

October 13, 2020October 13, 2020

New AI Algorithm Can Accurately Identify, Grade Prostate Cancer

News

A new artificial intelligence (AI) algorithm has been developed that can accurately detect and grade prostate cancer, using slide images from patient core needle prostate biopsies, a study reports. ... Read more

September 29, 2020September 29, 2020

Most nmCRPC Patients Can Safely Take Full Dose of Nubeqa, Trial Analysis Shows

News

Nearly all men with non-metastatic castration-resistant prostate cancer (nmCRPC) received the full planned dose of Nubeqa (darolutamide) tablets while participating in the ARAMIS Phase 3 trial, and few required ... Read more

September 17, 2020September 17, 2020

NCI Grant to Probe Link Between Prostate Cancer and Fatty Cells in Bone Marrow

News

A five-year grant of more than $2 million from the National Cancer Institute (NCI) will support research investigating the link between prostate cancer cells and the fatty cells — adipocytes — ... Read more

September 8, 2020September 8, 2020

IPCR Launches Exercise Video Series for Prostate Cancer Patients

News

The Institute for Prostate Cancer Research (IPCR), a collaborative effort between the Fred Hutchinson Cancer Research Center and UW Medicine, has launched a video series of exercises especially designed ... Read more

August 11, 2020August 11, 2020

Dosing Begins in Trial of PET Imaging Agent to Detect Prostate Cancer’s Return

News

The first patients have been injected in a Phase 3 trial investigating the safety and performance of Blue Earth Diagnostics‘ imaging agent rhPSMA-7.3 (18F) in detecting prostate cancer in men ... Read more

July 23, 2020July 23, 2020

New Risk Calculator May Help Men With High PSA Decide on Having Prostate Biopsy

News

A new risk calculator may help men with high levels of prostate-specific antigen (PSA) — a marker of prostate cancer — to decide if they should undergo a prostate ... Read more

July 15, 2020July 15, 2020

Laser Focal Therapy Effective, Causes Few Side Effects, 10-Year Trial Data Shows

News

Image-guided laser focal therapy is as effective as radical prostate removal surgery at treating men with localized prostate cancer, without the added risks of infection, incontinence, and erectile dysfunction, ... Read more

July 14, 2020July 14, 2020

University of Colorado Launches PreView Medical for PC Diagnosis, Treatment

News

The University of Colorado Anschutz Medical Campus, led by CU Innovations, has partnered with medical technology entrepreneurs Jonathan Gasson and Sharon Lake to form a new company called PreView ... Read more

July 9, 2020July 9, 2020

Vaccine Shows Promise in Advanced Prostate Cancer, Proof-of-Concept Study Shows

News

YourVaccx, a new type of cancer vaccine developed by ImmunSYS, is safe and shows promising effectiveness in patients with metastatic prostate cancer and other difficult-to-treat advanced solid tumors, a ... Read more

June 25, 2020June 25, 2020

Relugolix Granted FDA Priority Review as New Treatment Type

News

The U.S. Food and Drug Administration (FDA) has granted priority review to the new drug application (NDA) Myovant Sciences submitted earlier this year requesting the approval of relugolix for ... Read more

Pin It on Pinterest